(Epi-)genetics for preclinical diagnostics and preventative therapeutics for high-impact chronic neurodegenerative and rare pathologies
ToxGenSolutions has raised $263K in total funding. The most recent round was Grant. The last funding was announced in January 2023.
ToxGenSolutions's investors include European Union, Alzheimer's Drug Discovery Foundation, ToxGenSolutions, NWO, Eurostars.
ToxGenSolutions is headquartered in Maastricht, The Netherlands.
(Epi-)genetics for preclinical diagnostics and preventative therapeutics for high-impact chronic neurodegenerative and rare pathologies
ToxGenSolutions is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ToxGenSolutions — Funding & Investors." VCBacked, January 30, 2023, https://www.vcbacked.co/company/toxgensolutions. Accessed September 15, 2026.
VCBacked. (2023). ToxGenSolutions — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/toxgensolutions
{{cite web |title=ToxGenSolutions — Funding & Investors |url=https://www.vcbacked.co/company/toxgensolutions |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated